VXM01

· Vaximm GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VXM01, covering 2015-06-08 to 2022-10-20. Get the full timeline:

Most recent: Clinical Trial Update: VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma [Phase 1, Phase 2]